Publication details
Human Vdelta1 gamma-delta T cells exert potent specific cytotoxicity against primary multiple myeloma cells
| Authors | |
|---|---|
| Year of publication | 2012 |
| Type | Article in Periodical |
| Magazine / Source | Cytotherapy |
| MU Faculty or unit | |
| Citation | |
| Web | http://informahealthcare.com/doi/abs/10.3109/14653249.2012.700766 |
| Doi | http://dx.doi.org/10.3109/14653249.2012.700766 |
| Field | Oncology and hematology |
| Keywords | cytotoxicity; flow cytometry; gamma-delta cells; immunotherapy; multiple myeloma |
| Attached files | |
| Description | Human gamma-delta (gamma-delta) T cells are potent effector lymphocytes of innate immunity involved in anti-tumor immune surveillance. However, the Vdelta1 gamma-delta T-cell subset targeting multiple myeloma (MM) has not previously been investigated. We have shown for the first time that Vdelta1 T cells are highly myeloma-reactive and have therefore established Vdelta1 gamma-delta T cells as a potential candidate for a novel tumor immunotherapy. |